Literature DB >> 32800588

Reply to: Correspondence on "A new definition for metabolic associated fatty liver disease: an international expert consensus statement": MAFLD: Moving from a concept to practice.

Mohammed Eslam1, Jacob George2.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32800588     DOI： 10.1016/j.jhep.2020.06.036

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  3 in total

1.  Parthenolide plays a protective role in the liver of mice with metabolic dysfunction‑associated fatty liver disease through the activation of the HIPPO pathway.

Authors:  Weihong Wang; Yukai He; Qiuli Liu
Journal:  Mol Med Rep       Date:  2021-05-06       Impact factor: 2.952

2.  Metabolic-associated Fatty Liver Disease: Time to integrate ground-breaking new terminology to our clinical practice?

Authors:  Coskun Ozer Demirtas; Yusuf Yilmaz
Journal:  Hepatol Forum       Date:  2020-09-21

Review 3.  Management of Dyslipidemia in Patients with Non-Alcoholic Fatty Liver Disease.

Authors:  Hans-Michael Steffen; Philipp Kasper; Anna Martin; Sonja Lang; Tobias Goeser; Münevver Demir
Journal:  Curr Atheroscler Rep       Date:  2022-05-04       Impact factor: 5.967
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.